ICICI Securities has maintained its BUY rating on Star Cement but cut its target price to Rs 229 from Rs 251, still about 30% above the current market price of Rs 176.
News in Focus


Motilal Oswal Financial Services has reiterated its BUY rating on VIP Industries with a revised target price of Rs 300, about 26% above the current market price of Rs 238.

Walk into any urban dealership today, and the word SUV is attached to almost everything, even on cars with just plastic wheel-arch cladding and a slightly raised roofline.

Emkay Global Financial Services has retained its BUY rating on Hindustan Aeronautics (HAL) with an unchanged 12-month target price of Rs 5,950, implying about 23% upside from the current market pri

Cipla, Tata Consumer, State Bank of India, Trent, Maruti and Apollo Hospitals were among major gainers on NSE. At the time of publication of this report, NSE Nifty was trading 0.95 percent lower.

Ashok Leyland suffered major selling after the quarterly results but the stock still has potential to go up by nearly 20-25 percent from current levels.
Main Regional Stories

Senco Gold Shares were trading 2.2 percent lower on Wednesday. Gold was trading in the international markets at multiple-week lows.

Relaxo Footwears share price declined 2 percent in today's session. Motilal Oswal has suggested SELL Rating for the stock. IDBI Capital maintains a HOLD rating for the stock but has reduced target price.

Indian markets are expected to open strong as Nasdaq and Dow Futures were trading strong after Nvidia reported better-than-expected quarterly numbers.

ICICI Securities has maintained a HOLD rating on Tata Motors Passenger Vehicles with a sum-of-the-parts target price of Rs 275, about 3.5% below the current market price of Rs 285.

Stock market analyst Mitesh Thacker has maintained 'buy' rating on Suzlon Energy Ltd stock with a target of Rs 56.
Stock market analyst Somil Mehta of Sharekhan has maintained 'sell' rating on Hindalco Industries Limited stock with a target of Rs 175.
Stock market analyst Mitesh Thacker has maintained 'buy' rating on Sun Pharmaceutical Industries Limited stock with a target of Rs 1900.








